Assenagon Asset Management S.A. Trims Stake in Organogenesis (NASDAQ:ORGO)
Assenagon Asset Management S.A. lessened its position in Organogenesis (NASDAQ:ORGO – Free Report) by 88.6% in the 1st quarter, Holdings Channel.com reports. The fund owned 336,963 shares of the company’s stock after selling 2,613,886 shares during the period. Assenagon Asset Management S.A.’s holdings in Organogenesis were worth $1,456,000 at the end of the most recent […]
